Business Description
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-EBITDA | 1.76 | |||||
Interest Coverage | 48.06 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.55 |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 1 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.53 | |||||
Quick Ratio | 2.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 29 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 100 | |||||
Operating Margin % | 55.48 | |||||
Net Margin % | 48.7 | |||||
FCF Margin % | 2152.06 | |||||
ROE % | 1.7 | |||||
ROA % | 1.62 | |||||
ROIC % | 2.28 | |||||
ROC (Joel Greenblatt) % | 10.87 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 43.17 | |||||
PE Ratio without NRI | 51.8 | |||||
Shiller PE Ratio | 30.24 | |||||
PS Ratio | 17.92 | |||||
PB Ratio | 0.87 | |||||
Price-to-Tangible-Book | 0.87 | |||||
Price-to-Operating-Cash-Flow | 3.03 | |||||
EV-to-EBIT | 12.44 | |||||
EV-to-EBITDA | 12.44 | |||||
EV-to-Revenue | 7.03 | |||||
Price-to-Median-PS-Value | 1.38 | |||||
Price-to-Graham-Number | 1.3 | |||||
Price-to-Net-Current-Asset-Value | 12.33 | |||||
Price-to-Net-Cash | 12.33 | |||||
Earnings Yield (Greenblatt) % | 8.05 | |||||
FCF Yield % | 200.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Dexion Absolute Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 11.238 | ||
EPS (TTM) (€) | 0.056 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 2.4 - 2.65 | ||
Shares Outstanding (Mil) | 52.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Dexion Absolute Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Dexion Absolute Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Dexion Absolute Ltd Frequently Asked Questions
What is Dexion Absolute Ltd(LSE:DABE)'s stock price today?
When is next earnings date of Dexion Absolute Ltd(LSE:DABE)?
Does Dexion Absolute Ltd(LSE:DABE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |